Study on the Evaluation of Lung Cancer Patients from the Three Aspects of Emotion

Table 2

EORTC-QLQ-C30 evaluation of the QoL of patients with lung cancer ().

QLQ-C30	EORTC phase III-IV reference value (n = 1313)	Pre-chemotherapy score (n = 219)	T value	Post-chemotherapy score (n = 212)	F value
Cognitive function	85.3 ± 2.01	78.73 ± 19.74	−1.23	72.35 ± 22.09	4.89
Social function	68.8 ± 29.3	58.78 ± 26.31	−5.65	49.33 ± 31.83	5.76
Emotional function	67.3 ± 24.1	70.77 ± 21.66	2.28	67.75 ± 25.79	0.87
Physical function	64.9 ± 25.6	70.28 ± 23.86	2.60	56.63 ± 27.29	8.75
Role function	53.5 ± 31.3	63.52 ± 28.70	4.03	52.45 ± 32.74	8.20
Tired	43.2 ± 25.5	36.78 ± 19.96	−4.93	45.72 ± 25.69	10.23
Pain	34.5 ± 31.7	29.31 ± 21.85	−3.24	35.17 ± 28.56	3.00
Feel sick and vomit	10.8 ± 19.1	15.11 ± 22.35	2.74	24.00 ± 24.93	10.64
Insomnia	34.7 ± 33.4	27.42 ± 24.33	−4.26	46.67 ± 31.53	28.12
Difficulty breathing	40.7 ± 32.2	31.86 ± 25.97	−4.85	30.00 ± 30.08	0.67
Loss of appetite	31.1 ± 24.6	27.75 ± 27.38	−1.74	41.17 ± 23.26	12.51
Constipation	22.2 ± 21.7	19.38 ± 16.05	−1.54	31.17 ± 33.26	7.84
Financial difficulties	14.0 ± 24.3	48.75 ± 35.61	14.08	60.50 ± 35.38	4.81
Diarrhea	7.1 ± 8.3	7.88 ± 6.36	0.51	10.33 ± 9.88	0.92